MAGELLAN LONGEVITY
HomeResearchStudy library › Effect of vitamin K supplementation on arterial stiffness in vitamin…
Study summary · Cardiovascular & vascular aging

Does vitamin K supplementation affect serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients?

In one paragraph

Vitamin K2, a randomized, double-blind, placebo-controlled trial (Am J Transplant 2023, PMID 36695702) — vitamin K supplementation did not significantly affect calcification propensity (change in T50 vs baseline +2.3 ± 27.4 minutes for vitamin K vs +0.8 ± 34.4 minutes for placebo; P=.88). Vitamin K supplementation in kidney transplant recipients improved vitamin K status and prevented arterial stiffness progression, but did not change calcification propensity.

Source: Am J Transplant 2023, PMID 36695702 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Am J Transplant · 2023 · PMID 36695702 · DOI 10.1016/j.ajt.2022.12.015

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Vitamin K supplementation in kidney transplant recipients improved vitamin K status and prevented arterial stiffness progression, but did not change calcification propensity.

The question

Does vitamin K supplementation affect serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients?

What they tested

Vitamin K deficiency likely contributes to progressive vascular calcification and stiffness in kidney transplant recipients, suggesting that supplementation might improve these outcomes.

How they did it

This was a single-center, randomized, double-blind, placebo-controlled trial involving 40 vitamin K-deficient kidney transplant recipients. Participants were randomized 1:1 to receive either vitamin K2 (menaquinone-7, 360 μg/day) or placebo for 12 weeks. The primary endpoint was serum calcification propensity (T50), and secondary endpoints included arterial stiffness (pulse wave velocity [PWV]) and vitamin K status (dp-ucMGP).

What they found

Vitamin K supplementation did not significantly affect calcification propensity (change in T50 vs baseline +2.3 ± 27.4 minutes for vitamin K vs +0.8 ± 34.4 minutes for placebo; P= .88). However, it prevented the progression of PWV (change vs baseline -0.06 ± 0.26 m/s for vitamin K vs +0.27 ± 0.43 m/s for placebo; P= .010). Vitamin K status significantly improved with supplementation (change in dp-ucMGP vs baseline -385 pmol/L for vitamin K vs +39 pmol/L for placebo; P< .001), though most patients remained vitamin K-deficient.

Change in Pulse Wave Velocity (PWV) from Baseline
Values shown: Change in PWV (m/s)
Vitamin K Group-0.06
Placebo Group0.27

Vitamin K supplementation resulted in a decrease in pulse wave velocity, while the placebo group experienced an increase.

What it means

Vitamin K supplementation did not alter serum calcification propensity but prevented the progression of arterial stiffness in vitamin K-deficient kidney transplant recipients. This suggests that vitamin K may have vascular effects independent of calciprotein particles.

Limitations

The study was a single-center trial and, despite improved vitamin K status, most patients remained vitamin K-deficient, indicating that the dose or duration might not have been sufficient to fully correct the deficiency or impact calcification propensity. The abstract also suggests the need for longer-term intervention studies.

“vitamin K supplementation prevented progression of arterial stiffness compared with placebo”— from the published abstract, Am J Transplant 2023

The paper at a glance

TitleEffect of vitamin K supplementation on arterial stiffness in vitamin K-deficient kidney transplant recipients
JournalAm J Transplant
Year2023
PMID36695702 ↗
DOI10.1016/j.ajt.2022.12.015 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Vitamin K2 (MK-7)

In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating dephospho-uncarboxylated MGP by about half and markedly reducing undercarboxylated osteocalcin — and one well-run three-year randomized trial in healthy postmenopausal women found modestly improved arterial…

Vitamin K2 (MK-7)

Vitamin K2 (menaquinone) is a fat-soluble vitamin obtained from fermented foods such as natto and some…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does vitamin K supplementation affect serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients? [Plain-English summary of Am J Transplant 2023, PMID 36695702, DOI 10.1016/j.ajt.2022.12.015]. Magellan Longevity. https://magellanlongevity.com/study/d36695702.html
BibTeX
@misc{magellan_d36695702, title = {Does vitamin K supplementation affect serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d36695702.html}}, note = {Plain-English summary of PubMed PMID 36695702; DOI 10.1016/j.ajt.2022.12.015; Am J Transplant 2023. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d36695702.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 36695702 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.